Your browser version may not work well with NCBI's Web applications. More information here...
1: Bioorg Med Chem Lett. 2008 Jan 1;18(1):318-23. Epub 2007 Nov 19.Click here to read Links

Biphenyl amide p38 kinase inhibitors 1: Discovery and binding mode.

GlaxoSmithKline R&D, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, UK.

The biphenyl amides (BPAs) are a novel series of p38 MAP kinase inhibitors. The discovery of the series through structure-based focused screening is described, and the binding mode of the compounds is explained with reference to X-ray crystal structures.

PMID: 18006306 [PubMed - indexed for MEDLINE]

Structures reported by this article